Fundraising Fox
/Companies
Sign in

Veracyte

NASDAQ: VCYT

South San Francisco, US · Incorporated in Delaware · 3 known investors

Find your way into Veracyte

Each arrow is one introduction. Sign up to fill in the first one.

327 people can intro you to Marc

Ask Justin Kao to introduce you to Marc Stapley

You →Justin · together at Helix →Marc

310 people can intro you to Julie

Ask Jamie Chen to introduce you to Julie Brooks

You →Jamie · together at Perlegen Sciences →Julie

36 people can intro you to Shelly

Ask Sam Okafor to introduce you to Shelly Guyer

You →Sam · together at Nuvelo →Shelly

Sign up to find every way you can get introduced to Veracyte

  • Your email: who you already know at Veracyte, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Veracyte team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.

BiotechHealthtechMedical Devices

Founders & leadership

BHBonnie H. Anderson
Bonnie H. AndersonFounder
JBJulie Brooks
Julie BrooksExecutiveShe has over 25 years of experience in legal, governance, IP, and M&A roles across medical technology, life sciences, and software companies, with expertise in corporate governance, SEC reporting, and international transactions.
SDShelly D. Guyer
Shelly D. GuyerExecutiveShelly D. Guyer is an executive with over 30 years of finance experience spanning venture capital and public markets, having held leadership roles at life sciences companies including iRhythm and Invitae, where she managed IPOs, equity and debt financings, and helped scale revenue from early stages to $450M. She also serves on multiple corporate and nonprofit boards.
MS
Marc StapleyChief Executive OfficerMarc Stapley is Chief Executive Officer of Veracyte, a genomic diagnostics company that develops laboratory tests for cancer detection and treatment guidance. He brings experience across genomics, pharmaceuticals, telecommunications, software, and financial audit disciplines, and has served as a public company board member and audit committee chair.

Board

SD
Samuel D. ColellaBoard director
FE
Fred E. CohenBoard director
BG
Brian G. AtwoodBoard director
BHBrook H. Byers
Brook H. ByersBoard directorFounder, Kleiner Perkins
JI
Jesse I. TreuBoard director
EJ
Evan JonesBoard director
KE
Karin EasthamBoard director

Investors · 3

Kleiner Perkinslisted by Kleiner PerkinsMenlo Park · $500K – $15M

How we know: Kleiner Perkins's portfolio page · Not right? Tell us

Domain AssociatesreportedPrinceton · $200K – $15M

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$12.8M disclosed across 1 round · 2014

▶$12.8MraisedSep 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Julie BrooksExecutive Officer
  • Samuel D. ColellaDirector
  • Shelly D. GuyerExecutive Officer
  • Fred E. CohenDirector
  • Brian G. AtwoodDirector
  • Evan JonesDirector
  • Brook H. ByersDirector
  • Jesse I. TreuDirector
  • Karin EasthamDirector
  • Bonnie H. AndersonExecutive Officer, Director
Offering amount
$12.8M
Amount sold
$12.8M
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Veracyte went on to found or lead other companies.

Brook ByersDirectorFounded Insite Vision +1Marc StapleyChief Executive OfficerFounded Helix

Frequently asked questions

What does Veracyte do?
Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.
Who founded Veracyte?
Veracyte was founded by Bonnie H. Anderson.
Who are Veracyte's investors?
Veracyte's investors include Catalyst Health Ventures, Kleiner Perkins, Domain Associates.
How much funding has Veracyte raised?
Veracyte has disclosed $12.8M raised across 1 round.
Where is Veracyte headquartered?
Veracyte is headquartered in South San Francisco, US.